Sign in
Taking people in United StatesPhase 4

Contrast ultrasound to check blood flow after spinal cord injury

Tests perflutren ultrasound in people with acute spinal cord injury.

Key facts

Who runs it
University of Washington
Where
Seattle, United StatesSee the site
Trial code
Registry title
Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury
Status
Recruiting
Phase
Phase 4
People taking part
50 people, planned
Started
28 Sept 2023
Expected to end
15 Sept 2027
Type of study
Interventional
Treatments tested
  • Perflutren lipid
Record updated
27 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a spinal cord injury from trauma in the last 24 hours who will have spine surgery. It tests a contrast ultrasound scan of blood flow in the spinal cord.

Age
18 years and older.
Sex
All sexes can join.
Disease stage
Acute traumatic spinal cord injury for less than 24 hours, graded AIS A to AIS D. The injury must be at T10 or higher in the spine.
Earlier treatment
People must be medically stable enough to have routine spine surgery to relieve pressure, realign and fix the spine with rods and screws.

Main reasons for not taking part

  • Leg nerve exam missing or normal.
  • Head injury with a Glasgow score of 11 or lower.
  • Known allergy to lipid microspheres or their parts, such as polyethylene glycol (PEG), or past severe reactions to ultrasound contrast agents.
  • Known history of heart or lung conditions.
  • A cardiac shunt (an abnormal blood passage in the heart).

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • 18 years of age minimum
  • Acute spinal cord injury fpr less than 24 hours
  • Injury ranging from mild spinal cord injury where motor function is preserved (AIS A) to complete injury where there is no motor or sensory function below the leel of the injury (AIS D)
  • Medically stable to undergo routine dorsal decompression, spinal realignment
  • and stabilizing with segmental instrumentation

Who cannot take part

  • A history of anaphylactoid reactions from ultrasound enhancing agents
  • A known history of cardiopulmonary conditions
  • Cardiac shunt
  • Younger than 18 years old
  • Neurological lower extremity exam missing or intact
  • Traumatic head injury with a Glasgow score of 11 or lower
  • Cord injury level caudal to T10 (thoracic spine level 10)
  • A known sensitivity to lipid microsphere or its components, such as polyethylene glycol (PEG)

This trial is currently available in United States.

  • University of Washington - Harborview Medical CenterSeattle, United StatesContact: Amy M AndersonTaking people

About the trial

What the trial wants to find out

Patients with traumatic spinal cord injury (tSCI) often suffer from spinal cord swelling inside the thecal sac, which contains the spinal cord and surrounding fluid, leading to increased pressure on the spinal cord tissue and decreased spinal cord blood flow at the site of injury. The combination of increased pressure and decreased blood flow causes vascular hypoperfusion of the spinal cord and exacerbates the severity of injury. This is also referred to as secondary injury. Thus, knowledge of spinal cord hypoperfusion would allow the treating physician to optimize the hemodynamic condition of the patient with acute spinal cord injury and potentially improve functional outcomes.

The group in the trial

  • Contrast-enhanced ultrasound in traumatic spinal cord injuryTreatment being tested

    A bolus IV injection of Perflutren lipid contrast agent will be given. Continuous imaging will be obtained.

    Treatment: Perflutren lipid

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Contrast-Enhanced Ultrasound Biomarker for Prognostication and Guidance of Surgical Treatment in Acute Traumatic Spinal Cord Injury
Plain-language title
Contrast ultrasound to check blood flow after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
27 April 2025